IG Trading the Markets Podcast

[MongiIG]

 

 

IG Trading the Markets Podcast:

Cybersecurity specialist, Neira Jones, discusses recent concerns around data security as one of the main reasons for the intervention by Chinese authorities in the affairs of Chinese corporates in the West, including DiDi and Alibaba.

Our Podcasts are now available on Spotify, Apple Podcasts, Google Podcasts and Deezer Podcasts. You can also find more information by following the link here.

[MongiIG]

The latest episode of our Trading the Markets podcast is up on the website: https://www.ig.com/uk/trading-podcasts

Tesla: will Elon Musk signal strength for China deliveries?

As Tesla gets set to report second quarter earnings, Dan Ives, head of tech research at Wedbush, tells IGTV that the analyst community will be hoping to hear from CEO Elon Musk about the future of its deliveries in China. Ives is bullish on Tesla amid the ‘green tidal wave’ with a price target of $1000 a share, more than 50% above the current share price.

Elsewhere, Apple remains Ives’ top pick in the tech sector, which he says is still a buy heading into earnings. Ives is also favorable towards cybersecurity and the cloud including the likes of Microsoft, DocuSign, Nice and Zscaler.

 

 

 

[MongiIG]

IG Trading the Markets: our trading and investing podcast

Listen to the IG Trading the Markets podcast – covering topics such as current news, forex trading, commodity markets and stock trading and investment strategies.

 

 

Latest episode of the Trading the Markets podcast: https://www.ig.com/uk/trading-podcasts

 

Is the UK entering a period of stagflation?

 

With some members of the Bank of England talking about higher inflation for longer than the economy can withstand, will rates have to rise and will that rise stifle what growth there is?

 

In this episode, IGTV’s Jeremy Naylor talks to Martin Essex, analyst at Daily FX. Together they look at the prospects for the UK economy and how to trade sterling against the dollar and the euro.

[MongiIG]

PODCAST: Is Covid largely over or is the biotech sector ripe for more upside?

Investments in the biotech, pharmaceutical and life science sectors have seen some good returns since Covid struck.

While it is true that much of the initial gains have been retraced, Dr Navid Malik, a medically trained specialist who is now a life sciences, pharma and biotech analyst, says there is more to come as the sector prepares for more vaccines to combat new variants, and also brings the illusive Covid pill to the market.